Burnier M Egan BM 2019 The global epidemic of hypertension is largely uncontrolled and hypertension remains the leading cause of noncommunicable disease deaths worldwide. Suboptimal adherence, which includes failure to initiate pharmacotherapy, to take medications as often as prescribed, and to persist on therapy long-term, is a well-recognized factor contributing to the poor control of blood pressure in hypertension. Several categories of factors including demographic, socioeconomic, concomitant medical-behavioral conditions, therapy-related, healthcare team and system-related factors, and patient factors are associated with nonadherence. Understanding the categories of factors contributing to nonadherence is useful in managing nonadherence. In patients at high risk for major adverse cardiovascular outcomes, electronic and biochemical monitoring are useful for detecting nonadherence and for improving adherence. Increasing the availability and affordability of these more precise measures of adherence represent a future opportunity to realize more of the proven benefits of evidence-based medications. In the absence of new antihypertensive drugs, it is important that healthcare providers focus their attention on how to do better with the drugs they have. This is the reason why recent guidelines have emphasize the important need to address drug adherence as a major issue in hypertension management. https://sonar.ch/global/documents/248882 eng info:eu-repo/semantics/altIdentifier/doi/10.1161/CIRCRESAHA.118.313220 info:eu-repo/semantics/altIdentifier/pmid/30920917 Circulation research. - 2019 blood pressure cardiovascular diseases drug monitoring hypertension prevalence resistant hypertension Antihypertensive Agents Blood Pressure Guideline Adherence Humans Hypertension Medication Adherence Practice Guidelines as Topic Practice Patterns, Physicians' Risk Factors Treatment Outcome Adherence in Hypertension. http://purl.org/coar/resource_type/c_6501